FR2675155B1 - - Google Patents

Info

Publication number
FR2675155B1
FR2675155B1 FR9104523A FR9104523A FR2675155B1 FR 2675155 B1 FR2675155 B1 FR 2675155B1 FR 9104523 A FR9104523 A FR 9104523A FR 9104523 A FR9104523 A FR 9104523A FR 2675155 B1 FR2675155 B1 FR 2675155B1
Authority
FR
France
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
FR9104523A
Other languages
French (fr)
Other versions
FR2675155A1 (en
Inventor
Thierry Hercend
Frederic Triebel
Sergio Roman-Roman
Laurent Ferradini
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Sanofi Aventis France
Original Assignee
Roussel Uclaf SA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority to FR9104523A priority Critical patent/FR2675155A1/en
Application filed by Roussel Uclaf SA filed Critical Roussel Uclaf SA
Priority to CA002079881A priority patent/CA2079881C/en
Priority to KR1019920702512A priority patent/KR100227303B1/en
Priority to JP4506380A priority patent/JPH06502997A/en
Priority to IE044792A priority patent/IE920447A1/en
Priority to PCT/FR1992/000130 priority patent/WO1992013950A2/en
Priority to AU15445/92A priority patent/AU660306B2/en
Priority to EP92906703A priority patent/EP0528007A1/en
Publication of FR2675155A1 publication Critical patent/FR2675155A1/en
Application granted granted Critical
Publication of FR2675155B1 publication Critical patent/FR2675155B1/fr
Priority to US08/423,383 priority patent/US5700907A/en
Priority to US08/437,353 priority patent/US5830758A/en
Priority to KR1019997004635A priority patent/KR100297082B1/en
Priority to US10/095,672 priority patent/US7294712B2/en
Priority to US11/867,862 priority patent/US8709426B2/en
Granted legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
    • C12N15/113—Non-coding nucleic acids modulating the expression of genes, e.g. antisense oligonucleotides; Antisense DNA or RNA; Triplex- forming oligonucleotides; Catalytic nucleic acids, e.g. ribozymes; Nucleic acids used in co-suppression or gene silencing
    • C12N15/1138—Non-coding nucleic acids modulating the expression of genes, e.g. antisense oligonucleotides; Antisense DNA or RNA; Triplex- forming oligonucleotides; Catalytic nucleic acids, e.g. ribozymes; Nucleic acids used in co-suppression or gene silencing against receptors or cell surface proteins
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
    • C07K14/70503—Immunoglobulin superfamily
    • C07K14/7051—T-cell receptor (TcR)-CD3 complex
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/28—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
    • C07K16/2803—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants against the immunoglobulin superfamily
    • C07K16/2809—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants against the immunoglobulin superfamily against the T-cell receptor (TcR)-CD3 complex
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
FR9104523A 1990-06-04 1991-04-12 Nucleotide sequences encoding variable regions of beta chains of the receptors of human T lymphocytes, corresponding peptide segments and the diagnostic and therapeutic applications Granted FR2675155A1 (en)

Priority Applications (13)

Application Number Priority Date Filing Date Title
FR9104523A FR2675155A1 (en) 1991-04-12 1991-04-12 Nucleotide sequences encoding variable regions of beta chains of the receptors of human T lymphocytes, corresponding peptide segments and the diagnostic and therapeutic applications
EP92906703A EP0528007A1 (en) 1991-02-12 1992-02-12 NUCLEOTIDIC SEQUENCES CODING FOR VARIABLE REGIONS OF $g(b) CHAINS OF HUMAN T LYMPHOCYTE RECEPTORS, CORRESPONDING PEPTIDIC SEGMENTS AND DIAGNOSTIC AND THERAPEUTIC APPLICATIONS
JP4506380A JPH06502997A (en) 1991-02-12 1992-02-12 Nucleotide sequence encoding the variable region of the β chain of human T lymphocyte receptor and corresponding peptide segment and use in diagnosis and therapy
IE044792A IE920447A1 (en) 1991-02-12 1992-02-12 NUCLEOTIDE SEQUENCES CODING FOR ß-CHAIN VARIABLE REGIONS OF¹HUMAN T-LYMPHOCYTE RECEPTORS, CORRESPONDING PEPTIDE SEGMENTS¹AND DIAGNOSTIC AND THERAPEUTIC APPLICATIONS
PCT/FR1992/000130 WO1992013950A2 (en) 1991-02-12 1992-02-12 NUCLEOTIDIC SEQUENCES CODING FOR VARIABLE REGIONS OF β CHAINS OF HUMAN T LYMPHOCYTE RECEPTORS, CORRESPONDING PEPTIDIC SEGMENTS AND DIAGNOSTIC AND THERAPEUTIC APPLICATIONS
AU15445/92A AU660306B2 (en) 1991-02-12 1992-02-12 Nucleotidic sequences coding for variable regions of beta chains of human T lymphocyte receptors, corresponding peptidic segments and diagnostic and therapeutic applications
CA002079881A CA2079881C (en) 1991-02-12 1992-02-12 Nucleotidic sequences coding for variable regions of .beta. chains of human t lymphocite receptors, corresponding peptidic segments and diagnostic and therapeutic applications
KR1019920702512A KR100227303B1 (en) 1991-02-12 1992-02-12 Nucleotide sequences coding for variable regions of (beta) chains of human t lymphocyte receptors, corresponding peptidic segments and diagnostic and therapeutic applications
US08/423,383 US5700907A (en) 1991-02-12 1995-04-14 Nucleotide sequences coding for variable regions of β chains of human T lymphocyte receptors, corresponding peptide segments and the diagnostic and therapeutic uses
US08/437,353 US5830758A (en) 1991-02-12 1995-05-09 Isolated Vβ TCR antibodies
KR1019997004635A KR100297082B1 (en) 1991-02-12 1999-05-26 Nucleotides Sequences coding for Variable regions of β Chains of Human T lymphocyte Receptors, Corresponding Peptide Segments and the Diagonstic and Therapeutic Uses
US10/095,672 US7294712B2 (en) 1990-06-04 2002-03-12 Nucleotide sequences coding for variable regions of β chains of human T lymphocyte receptors, corresponding peptide segments and the diagnostic and therapeutic uses
US11/867,862 US8709426B2 (en) 1991-02-12 2007-10-05 Nucleotide sequence coding for variable regions of β chains of human T lymphocyte receptors, corresponding peptide segments and the diagnostic and therapeutic uses

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR9104523A FR2675155A1 (en) 1991-04-12 1991-04-12 Nucleotide sequences encoding variable regions of beta chains of the receptors of human T lymphocytes, corresponding peptide segments and the diagnostic and therapeutic applications

Publications (2)

Publication Number Publication Date
FR2675155A1 FR2675155A1 (en) 1992-10-16
FR2675155B1 true FR2675155B1 (en) 1995-01-20

Family

ID=9411791

Family Applications (1)

Application Number Title Priority Date Filing Date
FR9104523A Granted FR2675155A1 (en) 1990-06-04 1991-04-12 Nucleotide sequences encoding variable regions of beta chains of the receptors of human T lymphocytes, corresponding peptide segments and the diagnostic and therapeutic applications

Country Status (1)

Country Link
FR (1) FR2675155A1 (en)

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5223426A (en) * 1988-12-15 1993-06-29 T Cell Sciences, Inc. Monoclonal antibodies reactive with defined regions of the t-cell antigen receptor

Also Published As

Publication number Publication date
FR2675155A1 (en) 1992-10-16

Similar Documents

Publication Publication Date Title
DE9103004U1 (en)
DE9101085U1 (en)
DE9106515U1 (en)
DE9104137U1 (en)
DE9102185U1 (en)
DE9100507U1 (en)
DE9108736U1 (en)
DE9105276U1 (en)
DE9101448U1 (en)
DE9107429U1 (en)
DE9105363U1 (en)
DE9102432U1 (en)
DE9108193U1 (en)
DE9101311U1 (en)
DE9102356U1 (en)
DE9101172U1 (en)
DE9102497U1 (en)
DE9109956U1 (en)
DE9101004U1 (en)
DE9103009U1 (en)
DE9103612U1 (en)
DE9101958U1 (en)
DE9102485U1 (en)
DE9103433U1 (en)
DE9100420U1 (en)